Search bioRxiv⌕ Search

Biology subjects

Hofman, B.

Publications and source records attributed to Hofman, B..

2 recordsLinked to original sources

Primate Astrocyte Evolution Controls the Tempo of Neuronal Development

Prolonged neuronal maturation, also referred to as neoteny, constitutes a hallmark of human brain evolution. Yet, the mechanisms controlling neotenic brain development remain poorly understood, and have been defined as neuron-intrinsic. Astrocytes shape synapse formation, activity, and elimination, and have changed substantially between humans and other species. Yet, whether the evolutionary divergence in astrocytes shapes the timing of neuronal maturation is unknown. Here, we show that astrocytes from humans and their closest living relatives, chimpanzees, exert contrasting effects on neuronal maturation: chimpanzee astrocytes accelerate it, whereas human astrocytes delay it, without affecting neuronal survival. Through comparative transcriptomics and epigenomics, we find that evolutionarily reduced APOE expression in human astrocytes underlies the observed delay in neuronal maturation: restoring APOE levels in human astrocytes accelerates neuronal development. We further establish that the Hippo-TEAD signaling represses APOE expression in human astrocytes, revealing a link between the enhanced morphological complexity of human astrocytes and the observed reduced tempo of neuronal development in their presence. Strikingly, neuronal genes differentially impacted by human and chimpanzee astrocytes are associated with schizophrenia, Alzheimers disease, and epilepsy, linking astrocyte evolution to disease vulnerability. Altogether, these findings establish that brain neoteny is partly a glial phenomenon, revealing that understanding the pace of human brain development requires understanding how astrocytes, not only neurons, have evolved.

neuroscience↗

Chitinase-1 inhibition reverses metabolic dysregulation and restores homeostasis in MASH animal models

OATD-01 is a chitinase-1 (CHIT1) inhibitor, reducing inflammation and fibrosis in animal models where chronic inflammation leads to tissue remodeling. CHIT1, predominantly secreted by macrophages, is overexpressed in metabolic-dysfunction-associated steatohepatitis (MASH). In this study, we demonstrated the efficacy of OATD-01 in two murine and a rat model of MASH. RNA-Seq analysis revealed that OATD-01 reversed MASH-dysregulated genes. Apart from the attenuation of inflammation and fibrosis, OATD-01 regulated metabolic processes such as lipid metabolism and glycolysis. We demonstrated that both genetic and pharmacological inactivation of CHIT1 resulted in inhibition of glycolysis and glucose uptake in primary macrophages. As a consequence, we observed increased ATP, lower citrate and increased acetate levels, resulting in a reduced IL-1{beta} secretion. These results revealed the key role for CHIT1 in regulating metabolism. OATD-01 is a macrophage modulator that can directly restore metabolic balance and consequently inhibit inflammation and fibrosis, supporting its use for MASH treatment.

pharmacology and toxicology↗